These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. User fees and beyond--the FDA Safety and Innovation Act of 2012. Kramer DB, Kesselheim AS. N Engl J Med; 2012 Oct 04; 367(14):1277-9. PubMed ID: 23034017 [No Abstract] [Full Text] [Related]
3. Paying for drug approvals--who's using whom? Avorn J. N Engl J Med; 2007 Apr 26; 356(17):1697-700. PubMed ID: 17435083 [No Abstract] [Full Text] [Related]
7. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process. Bierut MB. Healthspan; 1992 Dec 26; 9(11):12-4. PubMed ID: 10123552 [No Abstract] [Full Text] [Related]
8. FDA joins market. Gershon D. Nature; 1993 Jul 08; 364(6433):93. PubMed ID: 8321293 [No Abstract] [Full Text] [Related]
12. US lawmakers tackle safety reforms at the FDA. Zwillich T. Lancet; 2007 Jun 16; 369(9578):1989-90. PubMed ID: 17577942 [No Abstract] [Full Text] [Related]
13. Regulatory watch: impact of PDUFA on regulatory decision-making. Hay M. Nat Rev Drug Discov; 2010 Aug 16; 9(8):585. PubMed ID: 20671755 [No Abstract] [Full Text] [Related]
17. FDA user fees approved. Clin Pharm; 1993 Jan 13; 12(1):3. PubMed ID: 8428431 [No Abstract] [Full Text] [Related]
18. Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI. Darrow JJ, Avorn J, Kesselheim AS. N Engl J Med; 2017 Dec 07; 377(23):2278-2286. PubMed ID: 29211663 [No Abstract] [Full Text] [Related]